On April 4, 2024 Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB) ("Sirona") reported that it has closed its private placement (Private Placement") for gross proceeds of $132,500 CAD. The Private Placement consists of 1,325,000 units, (the "Units") at a price of $0.10 per Unit (Press release, Sirona Biochem, APR 4, 2024, View Source;utm_medium=rss&utm_campaign=sirona-biochem-announces-close-of-private-placement [SID1234641816]). Each Unit consists of one common share and one transferable share purchase warrant, each whole warrant exercisable into one additional common share of the Company for a period of 2 years from the date of issue at a price of $0.15 per Share in year one and $0.25 per Share in year two. All securities issued under the Private Placement are subject to statutory hold periods expiring on August 4, 2024.
Proceeds will be used for general working capital purposes.
No insiders participated in the Private Placement.
No finders’ fees were paid from the Private Placement.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!